CARBAMAZEPINE SANDOZ L.P. 400 mg, film-coated tablet scored with extended release 30 tablets
Active ingredients: Carbamazepin
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored with extended release30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CARBAMAZEPINE SANDOZ L.P. 400 mg, comprimé pelliculé sécable à libération prolongée
- Pharmaceutical form
- comprimé pelliculé sécable à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC polyéthylène PVDC aluminium de 30 comprimé(s)
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 22 Jul 2025
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65883338CIP73443689CIP133400934436895Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CARBAMAZÉPINEcomprimé | 400,00 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.